Related Experiment Video

Updated: Aug 29, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Cdk inhibitor p27Kip1 and hormone dependence in breast cancer

Carlos L Arteaga1

  • 1Departments of Medicine and Cancer Biology and Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA. carlos.arteaga@vanderbilt.edu

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|January 22, 2004
PubMed

Insights

Low levels of the cell cycle regulator p27 (also known as cyclin-dependent kinase inhibitor 1B) are linked to increased cancer malignancy and resistance to antiestrogen therapies. This suggests alternative treatments for such tumors.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • p27Kip1 is a key regulator of the cell cycle, specifically the G1 to S transition.
  • It inhibits cyclin-dependent kinase (Cdk)2 and influences cyclin D/Cdk4 complex formation.
  • Functional downregulation of p27, through degradation or mislocalization, is common in cancers and associated with poor prognosis.

Purpose of the Study:

  • To investigate the role of p27Kip1 levels and localization in cancer malignancy.
  • To determine the association between p27Kip1 status and response to antiestrogen therapy.
  • To identify potential therapeutic strategies for tumors with altered p27Kip1 expression.

Main Methods:

  • Analysis of p27Kip1 expression levels and subcellular localization in various cancer types.
  • Correlation of p27Kip1 status with clinical data, including malignancy and patient prognosis.
  • Evaluation of p27Kip1 thresholds for predicting response to antiestrogen treatments.

Main Results:

  • Low p27Kip1 levels and/or cytoplasmic mislocalization are associated with enhanced malignancy and poor patient outcomes in cancers like breast cancer.
  • A specific threshold of p27Kip1 is necessary for effective response to antiestrogen therapies.
  • Conversely, low p27Kip1 levels predict resistance to antiestrogens.

Conclusions:

  • Functional downregulation of p27Kip1 contributes to cancer progression and malignancy.
  • p27Kip1 status serves as a predictive biomarker for antiestrogen therapy response.
  • Hormone receptor-positive tumors with low or cytoplasmic p27Kip1 may require alternative therapeutic strategies beyond antiestrogens.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...